electroCore’s gammaCore non-invasive vagus nerve stimulation – nVNS – has been selected to be a part of studies on effects of cannabinoids and alternative care on athlete pain management and performance. The NFL and NFLPA are jointly awarding two research grants to independent medical researchers at the American Society of Pain and Neuroscience and Emory University. The grants will fund investigations into first-of-their-kind, alternative pain management methods that could benefit NFL players, and society at large. The randomized study will compare nVNS and cannabidiol in contact sport athletes experiencing Post-Traumatic Headache to current standard of care treatment. The pilot data gathered in this study will guide future investigations into treatment of patients with post-traumatic headache.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ECOR:
- electroCore announces its TAC-STIM nVNS was selected to be part of AFRL A2PEX
- TAC-STIM™ Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project
- electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC
- electroCore to present poster on nVNS at American Headache Society meeting
- electroCore Announces Poster to be Presented at the American Headache Society’s 65th Annual Scientific Meeting